An IQVIA alternative deployed this week.
IQVIA is the incumbent for a reason: unmatched proprietary data and services at global-pharma scale. Oystercatcher is for teams that need working provider intelligence without a multi-quarter engagement.
Proprietary data at global scale
Longitudinal prescription data, claims assets, and global market coverage no public-data platform can replicate.
Services & consulting
Analytics teams, consulting engagements, and managed offerings for enterprise commercial organizations.
Enterprise integrations
Deep embeds into large pharma commercial stacks, built over decades.
Hours to deploy, not quarters
Self-serve signup, a free trial, and a working scored pipeline the same day — no implementation project, no services contract.
AI-first workflow
Natural-language targeting, explainable ML scoring, and agentic research with citations — the workflow is the product, not a dataset delivery.
Transparent, team-scale pricing
Published flat-base plans designed for mid-market teams — a fraction of a typical enterprise data engagement.
Public data, fully explained
Built on public datasets (NPI, CMS, Open Payments, state boards) with per-field provenance — auditable by anyone, including your compliance team.
Works inside your AI assistant
A full MCP connector — included on every paid plan and the free trial — lets Claude, ChatGPT, Cursor, or any MCP client run the whole workflow: plain-English search, campaign scoring, cited research, exports. Per-user OAuth consent, org-level admin controls, and a complete audit log. See the connector page.
You are a large commercial organization that needs proprietary longitudinal Rx/claims data, global coverage, and consulting capacity — and can run a major procurement.
You need provider targeting, scoring, and research your sales team can use this week, at mid-market pricing, on data whose provenance you can audit.
Publicly reported IQVIA engagements typically run $50,000–$100,000+/yr and can reach far higher with data licenses and services. Competitor pricing reflects publicly reported ranges and may vary by contract; verify with the vendor. Oystercatcher pricing is published on our pricing page.
Two workflows, two owners.
Selling to physicians divides into two jobs that share almost nothing, and tools in this category tend to serve one or the other. Knowing which one you are buying for is the fastest way to evaluate any option on this page — including ours.
Quarterly — campaign launch, territory reset
Daily — before each call or visit
The order matters: A sets the ceiling on B. Research on the wrong physician is careful work spent in the wrong place, so a tool that only prepares conversations inherits whatever list it is given. Oystercatcher is built for both — see how the four systems divide.
IQVIA alternatives, honestly.
If you are evaluating IQVIA alternatives, the honest first question is whether you actually need proprietary longitudinal prescription data — or working provider intelligence your sales team can use this week. The commonly evaluated alternatives:
Vendor descriptions are our good-faith reading of public positioning, not evaluations — verify capabilities and pricing with each vendor.
Switching questions.
Is Oystercatcher an IQVIA alternative?
For provider targeting and pre-call research at team scale, yes. IQVIA remains the incumbent for proprietary longitudinal prescription data, global coverage, and consulting capacity — Oystercatcher does not replicate that estate. What it replaces is the workflow: natural-language targeting, explainable 0–100 scoring, and cited research, self-serve, deployed in hours instead of quarters.
Does Oystercatcher have prescription data like IQVIA?
It has public prescribing data, not proprietary claims: CMS Part D prescriber files cover Medicare prescribing by drug and drug class, and CMS Part B covers procedures. That is narrower than IQVIA longitudinal Rx data — and fully auditable by your compliance team, with per-field provenance.
How fast can a team get value compared to an IQVIA engagement?
The same day. Signup is self-serve with a 14-day free trial (no card required), and there is no implementation project or services contract — you build a scored, researched call queue yourself rather than waiting on an engagement to stand one up.
Let the agents
do the research.
Your team does
what it does best.
Want proof first? Read an example dossier — sample data, real mechanics.